Risk Prediction Tool for Aggressive Tumors in Clinical T1 Stage Clear Cell Renal Cell Carcinoma Using Molecular Biomarkers

Some early-stage clear cell renal cell carcinomas (ccRCCs) of ≤7 cm are associated with a poor clinical outcome. In this study, we investigated molecular biomarkers associated with aggressive clinical T1 stage ccRCCs of ≤7 cm, which were used to develop a risk prediction tool toward guiding the deci...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Jee Soo, Lee, Hyo Jung, Cho, Nam Hoon, Kim, Jongchan, Jang, Won Sik, Heo, Ji Eun, Ham, Won Sik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Research Network of Computational and Structural Biotechnology 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6434066/
https://www.ncbi.nlm.nih.gov/pubmed/30962867
http://dx.doi.org/10.1016/j.csbj.2019.03.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6434066/
https://www.ncbi.nlm.nih.gov/pubmed/30962867
http://dx.doi.org/10.1016/j.csbj.2019.03.005

Ejemplares similares